Other
Feb 2026A company leader posted that Parallel Bio's San Diego team/site was recently closed due to a shift in business priorities.
SourceUsing the immune system to cure disease
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Parallel Bio is a biotechnology startup building human-first drug discovery tools that use patient-derived immune organoids, AI, and lab automation to predict how therapies will perform in diverse human biology, reduce reliance on animal testing, and support pharma partnerships plus its own cancer and autoimmune drug pipeline.
Primary product
Clinical Trial in a Dish: a human immune organoid platform for drug discovery and preclinical testing.
Founded
2021
Headquarters
Brisbane, CA, United States (San Francisco Bay Area)
Team size
20-30
Industry
Biotechnology
Sub-industry
Drug discovery / human organoid preclinical testing
Offices